This model is of proven relevance to cardiometabolic disease and provides a probe for the study of therapeutic and genomic influences on inflammatory effects in these disorders.17, 32–33 Abundant evidence links Toll-like receptor-4 signaling and subsequent activation of innate immunity with the pathogenesis of insulin resistance and atherosclerosis. The gene discussed is TLR4; the disease is atherosclerosis.